Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
Lescure et al., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(21)00099-0
https://c19early.org/lescure.html